To the Editor:
We thank Dr. Martin-Iglesias, et al for their comments1 on our recent case report published in The Journal2. We reported on a case of hydroxychloroquine (HCQ) retinopathy, and showcased the characteristic optical coherence tomography (OCT) and fundus autofluorescence imaging findings in a patient who had been taking approximately 13.6 mg/kg/day for 8 years, …
Address correspondence to Dr. D. Do, Byers Eye Institute, Department of Ophthalmology, 2452 Watson Court, Palo Alto, California 94303, USA. Email: Dianado{at}stanford.edu.